Form 4: HCA Healthcare Director Hugh F. Johnston Reports Acquisition and Disposal of Common Stock
SEC Form 4 Filing
Director Hugh F. Johnston reported acquiring and disposing of HCA Healthcare common stock on April 29, 2024, according to a Form 4 filing with the SEC.
Summary
- On April 29, 2024, Hugh F. Johnston, a director of HCA Healthcare, Inc., reported a transaction involving the company's common stock.
- Johnston acquired 610 shares of common stock at $0.00, representing restricted share units attributable to an annual director equity award.
- These shares will vest on the earlier of the company's 2025 annual shareholders' meeting or the first anniversary of the grant date.
- Vested shares will be delivered when Johnston ceases to be a member of the Board of Directors.
- Johnston also disposed of 2,640 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.
Positives
- The acquisition of restricted share units aligns the director's interests with the long-term performance of the company.
Future Outlook
The restricted share units will vest on the earlier of the company's 2025 annual shareholders' meeting or the first anniversary of the grant date, and vested shares will be delivered upon Johnston's departure from the Board of Directors.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their holdings in the company's stock.
Comparison to Industry Standards
- Form 4 filings are standard practice for directors and officers of publicly traded companies in compliance with SEC regulations.
- Equity awards are a common form of compensation for directors, aligning their interests with shareholders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the stock transactions of a company director.
Key Dates
| Date | Description |
|---|---|
| 2021-08-27 | Date of Power of Attorney execution. |
| 2024-04-29 | Date of transaction involving HCA Healthcare common stock. |
| 2024-05-01 | Date of signature for the report. |
| 2025 | Vesting of restricted share units will occur at the annual shareholders' meeting or the first anniversary of the grant date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.